跳至主要内容
临床试验/CTRI/2025/03/081693
CTRI/2025/03/081693尚未招募2 期

Role Of Individualized Homoeopathic Medicines In The Treatment Of Subclinical Hypothyroidism Using Synthesis Repertory An Open Label Prospective Clinical Study

National Institute Of Homoeopathy1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年3月18日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
40
试验地点
1
主要终点
To assess Serum TSH Level & Thyroid Symptom Rating Questionnaire (Thy-SRQ)

研究概览

简要总结

Subclinical Hypothyroidism is a clinical condition in which serum TSH is raised, and serum T3 and T4 concentrations are at the lower end of the reference range.

  1. Samples will be selected following preliminary and detailed screening using specified selection criteria.

  2. Inclusion and exclusion criteria are strictly followed.

  3. After consideration of dropout cases, a minimum 40 patients will be enrolled for the study.

  4. Case-taking will be done as per the strict homoeopathic principle.

  5. Baseline scoring will be taken using Thy-SRQ & and Serum TSH levels will be assessed.

  6. Analysis and evaluation of each case will be done.

  7. Miasmatic analysis will be done.

  8. Repertorization will be done in Synthesis Repertory.

  9. Final selection of the remedy will be done after consultation with Materia Medica.

  10. Potency, dose and repetition of the indicated remedies will be guided strictly as per homoeopathic principles.

  11. General (non-medicinal) management including appropriate diet and regimen will be advised.

  12. Subsequent prescriptions (follow-ups) will be generated according to relevant homoeopathic principles and will be recorded in follow-up sheets.

  13. The baseline data will be compared with the data obtained after 6 months.

  14. The score obtained by the patients will be compared and result will be analyzed as per appropriate statistical methods and interference will be done thereafter.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients of both sexes from any religion or socio-demographic background and aged between 18-65 years with high Serum TSH level but less than 20 mIU/ml (5-20 mIU/ml), and T3, T4 within normal range.
  • Patients agreeing to undergo T3, T4, TSH investigation, if required.
  • Patients willing to give written consent to participate in the study.

排除标准

  • Patients with serum TSH level more than 20 mIU/ml.
  • Pregnant or lactating women.
  • Patients taking any other treatment for subclinical hypothyroidism from other system of medicine.
  • Patients having the habits of substance abuse and/or dependence.
  • Patients having any uncontrolled systemic illness or any life-threatening disease.
  • Patients not willing to participate in the study, not willing to undergo any investigation, if so advised.

结局指标

主要结局

To assess Serum TSH Level & Thyroid Symptom Rating Questionnaire (Thy-SRQ)

时间窗: Baseline & 6 months

次要结局

  • Socio-demographic data(After 6 months)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Vaka Ashok Kumar

National Institute Of Homoeopathy

研究点 (1)

Loading locations...

相似试验